Skip to main content

RHUMBLINE ADVISERS

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in PTCT

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$14,475,036
-$1,320,846 QoQ
Shares Held
212,462
+2.2% QoQ
Ownership
0.256%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 43.66522013348269.ToString("F0")% Shared 0.ToString("F0")% None 56.3347798665173.ToString("F0")%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. PTCT ranks #20 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PTCT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $14,475,036 212,462
2025-12-31 $15,795,882 207,950
2025-09-30 $6,990,288 113,904
2025-06-30 $5,789,444 118,539
2025-03-31 $5,697,990 111,813
2024-12-31 $5,073,781 112,401
2024-09-30 $4,109,604 110,771
2024-06-30 $3,559,389 116,396
2024-03-31 $3,173,195 109,082
2023-12-31 $2,926,486 106,186
2023-09-30 $2,397,959 107,004
2023-06-30 $4,298,086 105,682
2023-03-31 $5,007,242 103,370
2022-12-31 $3,879,369 101,634
2022-09-30 $4,950,673 98,619
2022-06-30 $3,590,137 89,619
2022-03-31 $2,764,036 74,083
2021-12-31 $2,953,593 74,155
2021-09-30 $2,792,275 75,041
2021-06-30 $3,206,179 75,850
2021-03-31 $3,408,537 71,986
2020-12-31 $4,917,553 80,576
2020-09-30 $3,661,366 78,318
2020-06-30 $5,042,033 99,370
2020-03-31 $3,972,698 89,054